Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of adalimumab in moderate to severe chronic hidradenitis suppurativa
2008-004587-38Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of adalimumab in hidradenitis suppurativa (HS), sponsored by Abbott Laboratories. Primary endpoint: Clinical response at Week 16. Started Mar 2009; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2008-004587-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004587-38.